Development of Pharmaceutical Industry in Senegal.

ABSTRACTPharmaceutical industry in France stems from pharmacy practice and the State trusted pharmacist who had to control his company. Beginning in 1941, state gradually regulated and then controlled all activities of the drug industry, because of major impact of its products on Public Health. In Senegal, these old provisions have been taken over by article L596 of Book V. Pharmaceutical industrial sector is dependent on foreign manufacturers, where 85% of our drug needs are imported. The objective of our publication is to contribute to the development of local pharmaceutical industry. To achieve this, we have reviewed the literature on pharmaceutical industry and certain provisions of OHADA uniform act that encourage creation of pharmaceutical companies. US market remains the largest with 41% of the world market and Africa is the second most dynamic market with an average annual growth rate of more than 10%. In West Africa, Nigeria and Ghana are at the top. For a production emergence in third world, main obstacles lies at the level of patents and licenses. In Senegal, where 85 to 90% of drug used are imported, difficulties are related to registration, competition of imported products, and especially the lack of regional purchasing power stations weigh on the local industries. Today, where an incentive tax regime exists in Senegal, uniform act would be an opportunity to create new pharmaceutical companies.Keywords: Pharmaceutical industry - article L596 - uniform act - drug - Shareholders' agreements - Carriage agreement.